BDPT.US BioAdaptives Inc

Consumer Defensive Food Products USA Stocks
0.0012 USD
Close of Nov 14, 2026
0.0008 0.0380
Market cap
USD 236K
P/E
-
P/B
1,520.14x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is BDPT.US undervalued?

Graham number

The Graham number of BioAdaptives Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BioAdaptives Inc fundamental analysis

No fundamental analysis for BioAdaptives Inc yet.

BioAdaptives Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BioAdaptives Inc

BioAdaptives, Inc. investigates, markets, and distributes natural plant, fungi, and algal-based products and medical devices for humans and animals. The company offers MyndMed for immediate cognitive enhancement, medium-term resilience and memory gains, and long-term neuroprotection and cognitive health; Zeranovia, a weight loss enhancer; Wynovia to help reduce the loss of lean muscle mass during dieting; and Xcellara, a regenerative wellness solution. It also provides canin…

Full company profile